Familial adenomatous polyposis

Seminars in Surgical Oncology

Volumn 18, Issue 4, 2000, Pages 314-323

  Lal, Geeta ^b   Gallincer, Steven ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

Adenomatous polyposis coli; Aggressive fibromatosis; APC genes; Brain neoplasms genetics; Colectomy; Colorectal neoplasms; Cyclooxygenase inhibitors; Endoscopy; Epidermal cyst; Gardner syndrome; Genetic counseling; Genetic screening; Genetics diagnosis pathology surgery; Heterozygote detection; Hypertrophy congenital pigment epithelium of eye; Ileostomy; Incidence; Intestinal polyps; Linkage (genetics); Mice; Mutation; Non steroidal anti inflammatory agents; Osteoma; Postoperative complications; Restorative proctocolectomy; Sulindac

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CHROMOSOME 5Q; DIAGNOSTIC APPROACH ROUTE; FAMILIAL CANCER; GARDNER SYNDROME; GENETIC LINKAGE; GENOTYPE; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI; DIAGNOSIS, DIFFERENTIAL; GENES, APC; GENETIC SCREENING; GENOTYPE; HUMANS; PEDIGREE; PHENOTYPE; POLYPS;

EID: 0034106505     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(200006)18:4<314::AID-SSU6>3.0.CO;2-9     Document Type: Article

References (90)

1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. Campbell WJ, Spence RA, Parks TG: Familial adenomatous polyposis [Review]. Br J Surg 1994;81:1722-1733.
3. Bisgaard ML, Fenger K, Bulow S, et al: Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994;3:121-125.
4. Phillips RK, Spigelman AD, Thomson JP (eds): "Familial adenomatous polyposis and other polyposis syndromes." Boston: Edward Arnold; 1994.
5. Petersen GM: Genetic testing and counseling in familial adenomatous polyposis. Oncology [Review]. 1996;10:89-94.
6. Rustgi AK: Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 1994;331:1694-1702.
7. Stigt JA, Vasen HF, van der Linde K, van Vliet AC: Thyroid carcinoma as first manifestation of familial adenomatous polyposis [Review]. Neth J Med 1996;49:116-118.
8. Clark SK, Pack K, Pritchard J, Hodgson SV: Familial adenomatous polyposis presenting with childhood desmoids [letter]. Lancet 1997;349(9050):471-472.
9. Campbell WJ, Spence RA, Parks TG: The role of congenital hypertrophy of the retinal pigment epithelium in screening for familial adenomatous polyposis. Int J Colorectal Dis 1994;9:191-196.
10. Tiret A, Taiel-Sartral M, Tiret E, Laroche L: Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol 1997;81:755-758.
11. Berk T, Cohen Z, McLeod RS, Parker JA: Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Dis Colon Rectum 1988;31:253-257.
12. Gurbuz AK, Giardiello FM, Petersen GM, et al: Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-381.
13. Reitamo JJ, Hayry P, Nykyri E, Saxen E: The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665-673.
14. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, Petrelli NJ: Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994;74:1270-1274.
15. Lynch HT, Fitzgihbons R Jr: Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review [Review]. Am J Gastroenterol 1996;91:2598-2601.
16. Penna C, Tiret E, Parc R. et al: Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gynecol Obstet 1993;177:263-268.
17. Goellner JR, Soule EH: Desmoid tumors. An ultrastructural study of eight cases. Hum Pathol 1980;11:43-50.
18. Clark SK, Phillips RK: Desmoids in familial adenomatous polyposis [Review]. Br J Surg 1996;83:1494-1504.
19. Debinski HS, Spigelman AD, Hatfield A, et al: Upper intestinal surveillance in familial adenomatous polyposis. Eur J Cancer 1995;31A:1149-1153.
20. Arvanitis ME, Jagelman DG, Fazio VW, et al: Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990;33: 639-642.
21. Belchetz LA, Berk T, Bapat BV, et al: Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996;39:384-387.
22. Nugent KP, Spigelman AD, Phillips RK: Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg 1996;83:1121-1122.
23. Giardiello FM, Offerhaus GJ, Lee DH, et al: Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993;34:1394-1396.
24. Cetta F, Prevalence, significance, and biological behavior of ret/ PTC1 associated papillary thyroid carcinoma [letter]. J Clin Endocrinol Metab 1997;82:1650.
25. Gardner E, Richards RC: Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1953;5:139-147.
26. Hamilton SR, Liu B, Parsons RE, et al: The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-847.
27. Paraf F, Jothy S, Van Meir EG: Brain tumor-polyposis syndrome: two genetic diseases? [Review]. J Clin Oncol 1997;15:2744-2758.
28. Herrera L, Kakati S, Gibas L, et al: Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986;25: 473-476.
29. Kinzler KW, Nilbert MC, Su LK, et al: Identification of FAP locus genes from chromosome 5q21. Science 1991;253(5020):661-665.
30. Nishisho I, Nakamura Y, Miyoshi Y. et al: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253(5020):665-669.
31. Groden J, Thliveris A, Samowitz W, et al: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
32. Joslyn G, Carlson M, Thliveris A, et al: Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991;66:601-613.
33. Beroud C, Soussi T: APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1996;24:121-124.
34. Miyoshi Y, Ando H, Nagase H, et al: Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sei U S A 1992;89:4452-4456.
35. Nagase H, Nakamura Y: Mutations of the APC (adenomatous polyposis coli) gene [Review]. Hum Mutat 1993;2:425-434.
36. Peifer M, Pai LM, Casey M: Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for wingless signal and zeste-whi'te 3 kinase. Dev Biol 1994;166:543-556.
37. Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 1993;262(5140):1734-1737.
38. Smith KJ, Levy DB, Maupin P, et al: Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 1994;54:3672-3675.
39. Leppert M, Burt R, Hughes JP, et al: Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 1990;322:904-908.
40. Spirio L, Otterud B, Stauffer D, et al: Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 192;51:92-100.
41. Soravia C, Berk T, Madlensky L, et al: Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998;62:1290-1301.
42. OIschwang S, Tiret A, Laurent-Puig P, et al: Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993;75:959-968.
43. Wallis YL, Macdonald F, Hulten M, et al: Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet 1994;94:543-548.
44. Caspari R, Olschwang S, Friedl W, et al: Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995;4:337-340.
45. Sanabria JR, Croxford R, Berk TC, et al: Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. Am J Surg 1996;171:136-141.
46. Paul P, Letteboer T, Gelbert L, et al: Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Hum Mol Genet 1993;2:925-931.
47. Dietrich WF, Lander ES, Smith JS, et al: Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-639.
48. Spirio LN, Kutchera W, Winstead MV, et al: Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res 1996;56:955-958.
49. Kennedy BP, Soravia C, Moffat J, et al: Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res 1998;58:500-503.
50. Laken SJ, Petersen GM, Gruber SB, et al: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79-83.
51. Gryfe R, Di Nicola N, Lal G, et al: Inherited colorectal polyposis and cancer risk of the APCI1307K polymorphism. Am J Hum Genet 1999;64:378-384.
52. Moser AR, Mattes EM, Dove WF, et al: ApcMin, a mutation in the murine Ape gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A 1993;90:8977-8981.
53. Fodde R, Edelmann W, Yang K, et al: A targeted chain-termination mutation in the mouse Ape gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 1994;91:8969-8973.
54. Fodde R, Smits R, Hofland N, et al: Mechanisms of APC-driven tumorigenesis: lessons from mouse models. Cytogenet Cell Genet 1999;86:105-111.
55. Oshima M, Oshima H, Kitagawa K, et al: Loss of Ape heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Ape gene. Proc Natl Acad Sci U.S.A. 1995;92:4482-4486.
56. Reitmair AH, Cai JC, Bjerknes M, et al: MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res 1996;56:2922-2926.
57. Petersen GM, Slack J, Nakamura Y: Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991;100:1658-1664.
58. Bapat BV, Parker JA, Berk T, et al: Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines. Dis Colon Rectum 1994;37:165-171.
59. Powell SM, Petersen GM, Krush AJ, et al: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329:1982-1987.
60. Papadopoulos N, Leach FS, Kinzler KW, Vogelstein B: Monoallelic mutation analysis (MAMA) for identifying germline mutations. Nat Genet 1995;11:99-102.
61. Terdiman JP, Conrad PG, Sleisenger MH: Genetic testing in hereditary colorectal cancer: indications and procedures [Review]. Am J Gastroenterol 1999;94:2344-2356.
62. Giardiello FM, Hamilton SR, Krush AJ, et al: Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-1316.
63. Sheng H, Shao J, Morrow JD, et al: Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-366.
64. Chan TA, Morin PJ, Vogelstein B, Kinzler KW: Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 1998;95:681-686.
65. Elder DJ, Paraskeva C: COX-2 inhibitors for colorectal cancer [news]. Nat Med 1998;4:392-393.
66. Oshima M, Dinchuk JE, Kargman SL, et al: Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-809.
67. Richard CS, Berk T, Bapat BV, et al: Sulindac for periampullary polyps in FAP patients. Int J Colorectal Dis 1997;12:14-18.
68. Niv Y, Fraser GM: Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994;107:854-857.
69. Tsukada K, Church JM, Jagelman DG, et al: Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35:29-33.
70. Schnitzler M, Cohen Z, Blackstein M, et al: Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum, 1997;40:798-801.
71. Todo S, Reyes J, Furukawa H, Abu-Elmagd K, et al: Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995; 222:270-282.
72. Misiakos EP, Pinna A, Kato T, et al: Recurrence of desmoid tumor in a multivisceral transplant patient with Gardner's syndrome. Transplantation 1999;67:1197-1199.
73. Setti-Carraro P, Nicholls RJ: Choice of prophylactic surgery for the large bowel component of familial adenomatous polyposis [Review]. Br J Surg 1996;83:885-892.
74. DeCosse JJ, Cennerazzo W: Treatment options for the patient with colorectal cancer [Review]. Cancer 1992;70(5 Suppl):1342-1345.
75. Iwama T, Mishima Y: Factors affecting the risk of rectal cancer following rectum-preserving surgery in patients with familial adenomatous polyposis. Dis Colon Rectum 1994;37:1024-1026.
76. Nugent KP, Spigelman AD, Nicholls RJ, et al: Pouch adenomas in patients with familial adenomatous polyposis. Br J Surg 1993; 80:1620.
77. van Duijvendijk P, Vasen HF, Bertario L, et al: Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis. J Gastrointest Surg 1999;3:325-330.
78. von Herbay A, Stern J, Herfarth C: Pouch-anal cancer after restorative proctocolectomy for familial adenomatous polyposis. Am J Surg Pathol 1996;20:995-99.
79. Fazio VW, Ziv Y, Church JM, et al: Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222: 120-127.
80. McLeod RS, Lavery IC, Leatherman JR, et al: Patient evaluation of the conventional ileostomy. Dis Colon Rectum 1985;28: 152-154.
81. Gilson TP, Sollenberger LL: Adenocarcinoma of an ileostomy in a patient with familial adenomatous polyposis. Report of a case [Review], Dis Colon Rectum 1992;35:261-265.
82. rd, Talton DS, Poole GV: Adenocarcinoma of a Brooke ileostomy for adenomatous polyposis coli [Review]. Am J Gastroenterol 1993;88:1122-1124.
83. Kock NG: Intra-abdominal "reservoir" in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal "continence" in five ileostomy patients. Arch Surg 1969; 99:223-231.
84. Vasen HF, van der Luijt RB, Slors JF, et al: Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348(9025):433-435.
85. Wu JS, Paul P, McGannon EA, Church JM: APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1998;227:57-62.
86. Church JM: The ileal pouch-anal anastomosis in challenging patients: stretching the limits. Aust N Z J Surg 1995;65:104-106.
87. Bapat B, Noorani H, Cohen Z, et al: Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut 1999;44:698-703.
88. Berk T, Cohen Z, Bapat B, Gallinger S: Negative genetic test result in familial adenomatous polyposis: clinical screening implications. Dis Colon Rectum 1999;42:307-312.
89. Spigelman AD, Williams CB, Talbot IC, et al: Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2(8666):783-785.
90. Soravia C, Berk T, Haber G, et al: Management of advanced duodenal polyposis in familial adenomatous polyposis. J Gastrointest Surg 1997;1:474-478.